Menveo Meningitis Vaccine Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
- MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age \n
- MENVEO is supplied in two vials that must be combined prior to administration: reconstitute the MenA lyophilized conjugate vaccine component with the MenCYW-135 liquid conjugate vaccine component immediately before administration
- Generic drug code:
- 28272
- Application:
- meningitis vaccine
- Brand:
- Menveo
- Generic drug name:
- meningococcal (groups a c y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine preservative free
- Manufacturer #:
- 58160095509
- Storage requirements:
- requires refrigeration
- Strength:
- 10 mcg - 5 mcg / 0.5 ml
- Container type:
- single dose vial
- Dosage form:
- injection
- Product dating:
- mckesson acceptable dating: we will ship >= 60 days
- Mckesson #:
- 1064517
- Refno:
- 3677333
- NDC number:
- 58160-0955-09
- Manufacturer:
- Glaxo Smith Kline
- Volume:
- 0.5 ml
- Type:
- intramuscular
- UNSPSC:
- 51201610
